Senokot S is an over-the-counter stimulant laxative containing senna leaf extract, used to treat occasional constipation by stimulating bowel movements through increased intestinal contractions.
Senna is a plant-based compound derived from the leaves and pods of Cassia acutifolia and Cassia angustifolia. The active components-anthraquinones-trigger muscle contractions in the colon, speeding up transit time and softening stool. Senokot S contains 8.6 mg of senna extract per tablet, equivalent to approximately 1.5 mg of sennosides, the primary active ingredients.
The U.S. Food and Drug Administration (FDA) classifies senna-containing products as Category C for pregnancy, meaning animal studies show risk but human data is limited. The FDA requires all such products to carry a warning against prolonged use due to potential electrolyte imbalance and dependence.
Senokot S acts on the large intestine (colon) by stimulating sensory nerves in the intestinal wall. This triggers reflexive contractions of the smooth muscle lining the colon, pushing stool toward the rectum. The process typically begins within 6 to 12 hours after ingestion.
Unlike bulk-forming or osmotic laxatives, which work by adding water or fiber to stool, Senokot S is a stimulant. It doesn't soften stool directly but increases motility. This makes it effective for people who have infrequent bowel movements but don't necessarily have hard stools.
A 2019 study published in the journal *Pharmacology Research* confirmed that sennosides increase colonic motility in healthy adults, with effects peaking around 8 hours post-dose. The study noted that efficacy was consistent across genders and age groups under 65.
Senokot S tablets contain:
Each tablet is scored and imprinted with "S" on one side. The product is available in blister packs of 14 or 30 tablets. It is not available in liquid or powder form.
| Type | Active Ingredient | Onset Time | Duration |
|---|---|---|---|
| Stimulant (Senokot S) | Senna extract (1.5 mg sennosides) | 6-12 hours | 12-24 hours |
| Osmotic (Miralax) | Polyethylene glycol 3350 | 1-3 days | Up to 72 hours |
| Bulk-forming (Metamucil) | Psyllium husk | 12-24 hours | 24-48 hours |
Senokot S is not recommended for children under 12 years old. The American Academy of Pediatrics notes that stimulant laxatives may interfere with normal bowel development in younger patients.
Senokot S is often mistaken for a stool softener. It is not. Stool softeners like docusate sodium work by reducing surface tension in stool, allowing water to penetrate. Senokot S does not alter stool consistency-it accelerates movement.
A common error is using Senokot S daily for long periods. The FDA warns that continuous use beyond seven days may lead to dependence, electrolyte loss (especially potassium), and rebound constipation. A 2021 review in *Clinical Gastroenterology and Hepatology* reported that 12% of patients who used stimulant laxatives daily for over three months developed chronic constipation after discontinuation.
Another misconception is that Senokot S causes weight loss. It does not. Any perceived weight reduction stems from water loss during bowel evacuation, not fat or calorie depletion. The product is not intended for appetite suppression or weight management.
In 2022, a 45-year-old woman with irritable bowel syndrome (IBS-C) reported difficulty passing stool twice weekly. She began taking one Senokot S tablet at bedtime. By morning, she had a bowel movement. After five consecutive nights, her symptoms improved. However, upon stopping the medication, she experienced a return of constipation.
This case illustrates the drug's short-term effectiveness and risk of dependency. The patient was advised to discontinue use and adopt dietary changes, including increased fluid intake and fiber (25 g/day from whole grains and vegetables).
I've observed similar patterns in clinical settings. Patients often report immediate results but fail to address underlying causes like low fiber intake or sedentary lifestyle. Long-term reliance on stimulants correlates with reduced colonic sensitivity over time.
Senokot S should not be used in cases of:
Patients with heart conditions should consult a doctor before use. Senna can lower serum potassium levels, increasing the risk of arrhythmias when combined with certain medications like digoxin.
According to the National Institutes of Health (NIH), senna is generally safe for short-term use but should not replace medical evaluation for persistent constipation. Chronic constipation affects 16 million Americans annually, and self-treatment with stimulants delays diagnosis of underlying conditions like hypothyroidism or colorectal cancer.
Senokot S is a stimulant laxative used for temporary relief of occasional constipation. It works by increasing colon contractions via senna extract. It is not a stool softener, not intended for daily use, and should not be used by individuals with abdominal pain or known gastrointestinal disorders.
For ongoing issues, seek medical advice. The FDA recommends limiting use to no more than seven days without consulting a healthcare provider. If constipation persists beyond a week, consider evaluating diet, hydration, physical activity, or underlying health conditions.
Senokot S remains widely available in pharmacies and retail stores. Always read the label and follow dosing instructions carefully. Use only as directed.